Literature DB >> 12668210

Distribution of neuropeptide Y Y1 and Y2 receptors in the postmortem human heart.

Ann Cathrine Jönsson-Rylander1, Margareta Nordlander, Aud Svindland, Arnfinn Ilebekk.   

Abstract

In the present study, we present for the first time the presence and distribution of neuropeptide Y (NPY) receptors Y1 and Y2 in the human postmortem heart using specific antibodies raised against extracellular parts of the receptors. A more intensive staining against the Y2 than against the Y1 receptors was detected on both atrial and ventricular cardiomyocytes. Immunoreactivity against both receptors was identified on both conducting fibers and cardiac nerves. More vessels stained positively for the Y2 than for the Y1 receptor, but the Y1 receptors were more abundant in subendocardial than subepicardial vessels of the left ventricular wall.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668210     DOI: 10.1016/s0196-9781(03)00041-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue.

Authors:  Robina Matyal; Feroze Mahmood; Michael Robich; Hiliary Glazer; Kamal Khabbaz; Philip Hess; Cesario Bianchi; Robert Hagberg; Shu-Xu Hu; Frank W Sellke
Journal:  Eur J Pharmacol       Date:  2011-04-28       Impact factor: 4.432

2.  Expression of Neuropeptide Y, Substance P, and their receptors in the right atrium of diabetic patients.

Authors:  Asma Ejaz; Frank W LoGerfo; Kamal Khabbaz; Leena Pradhan
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

3.  Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.

Authors:  C Lu; L Everhart; J Tilan; L Kuo; C-C J Sun; R B Munivenkatappa; A-C Jönsson-Rylander; J Sun; A Kuan-Celarier; L Li; K Abe; Z Zukowska; J A Toretsky; J Kitlinska
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

4.  Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.

Authors:  Eckhard Schwertfeger; Thomas Klein; Oliver Vonend; Vitus Oberhauser; Johannes Stegbauer; Lars Christian Rump
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-22       Impact factor: 3.000

Review 5.  Autonomic control of the heart: going beyond the classical neurotransmitters.

Authors:  Neil Herring
Journal:  Exp Physiol       Date:  2014-11-20       Impact factor: 2.969

Review 6.  The Role of Neuropeptide Y in Cardiovascular Health and Disease.

Authors:  Cheryl M J Tan; Peregrine Green; Nidi Tapoulal; Adam J Lewandowski; Paul Leeson; Neil Herring
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.